Related Experiment Video
Updated: Jun 30, 2026
08:04
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
Published on: March 18, 2014
Ferulic acid promoting apoptosis in human osteosarcoma cell lines
Xu-Dong Zhang1, Qiang Wu2, Shu-Hua Yang3
1Dr. Xu-dong Zhang, Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pakistan Journal of Medical Sciences
|April 4, 2017
Summary
Ferulic acid (FA) effectively reduces osteosarcoma cell viability by promoting apoptosis. FA activates key proteins like caspase-3 and Bax while downregulating Bcl-2, offering a potential therapeutic strategy for osteosarcoma.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Osteosarcoma is a primary bone malignancy with limited treatment options.
- Ferulic acid (FA), a natural phenolic compound, exhibits potential antitumor properties.
Purpose of the Study:
- To investigate the apoptosis-promoting and antitumor effects of ferulic acid (FA) on human osteosarcoma cells.
- To elucidate the underlying molecular mechanisms of FA's action.
Main Methods:
- Human osteosarcoma cell lines (SaOS-2 and MG63) were treated with varying concentrations of FA.
- Cell viability was assessed using MTT assay.
- Apoptosis was evaluated via flow cytometry (Annexin V/PI staining).
- Protein and gene expression of apoptosis-related markers (caspase-3, procaspase-3, Bcl-2, Bax) were analyzed by Western blot and qPCR.
Main Results:
- FA significantly decreased osteosarcoma cell viability in a dose-dependent manner (P < 0.01).
- FA treatment led to a dose-dependent increase in apoptosis (P < 0.05).
- FA upregulated caspase-3 and Bax (protein and mRNA) while downregulating procaspase-3 and Bcl-2 (protein and mRNA) expression.
Conclusions:
- Ferulic acid demonstrates significant antitumor activity against osteosarcoma cells by inducing apoptosis.
- FA's mechanism involves the activation of caspase-3 and Bax, and the inhibition of Bcl-2.
- FA presents a promising therapeutic agent for osteosarcoma treatment.
